Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty.

BMC nephrology

Volumn 14, Issue , 2013, Pages

  Juma, Salima ^a   Thomson, Benjamin K A ^b   Lok, Charmaine E ^b   Clase, Catherine M ^b   Blake, Peter G ^b   Moist, Louise ^b  

^a WESTERN UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; ATRIAL FIBRILLATION; CANADA; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; NEPHROLOGY; PHYSICIAN; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; STANDARDS;

ADULT; ANTICOAGULANTS; ATRIAL FIBRILLATION; CANADA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHROLOGY; PHYSICIANS; RENAL DIALYSIS; RISK FACTORS; WARFARIN;

EID: 84881297396     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-174     Document Type: Article

References (0)